← Vicat overview

Vicat vs Martin Marietta Materials: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Vicat S.A. (VCT.PA)

Martin Marietta Materials Inc (MLM)

Q3 2026
▲2

Martin Marietta's $13.5B Lhoist deal clears path as Q2 hits records

  • Lhoist acquisition clears regulatory hurdle All regulatory approvals are now in for the $13.5 billion Lhoist North America deal, expected to close in Q3 2026. This removes a major uncertainty and should let the company become the top U.S. lime and limestone producer, boosting future earnings and margins.

    This is a new, concrete step that de-risks the largest deal in company history and directly affects MLM's future earnings power.

  • Record Q2 results and raised guidance MLM reported record Q2 revenue of $1.95 billion (up 21%) and adjusted EPS of $5.00, beating estimates. It raised full-year revenue guidance to $7.2–$7.4 billion and reaffirmed EBITDA guidance, showing strong demand for aggregates and lime.

    This is fresh evidence of the company's underlying business strength and supports the bull case for the stock.

  • Premium valuation and lowered earnings estimate Despite the earnings beat, MLM trades at 26.2 times forward earnings, above its industry average and five-year median. The consensus current-year earnings estimate has slipped 1.4% in four weeks, and Zacks rates the stock a Hold, suggesting limited upside from here.

    This is the main counterweight: even with good news, the stock's high price and slightly falling profit forecasts could cap gains.

July 2026
▲2

Martin Marietta's $13.5B Lhoist deal clears path as Q2 hits records

  • Lhoist acquisition clears regulatory hurdle All regulatory approvals are now in for the $13.5 billion Lhoist North America deal, expected to close in Q3 2026. This removes a major uncertainty and should let the company become the top U.S. lime and limestone producer, boosting future earnings and margins.

    This is a new, concrete step that de-risks the largest deal in company history and directly affects MLM's future earnings power.

  • Record Q2 results and raised guidance MLM reported record Q2 revenue of $1.95 billion (up 21%) and adjusted EPS of $5.00, beating estimates. It raised full-year revenue guidance to $7.2–$7.4 billion and reaffirmed EBITDA guidance, showing strong demand for aggregates and lime.

    This is fresh evidence of the company's underlying business strength and supports the bull case for the stock.

  • Premium valuation and lowered earnings estimate Despite the earnings beat, MLM trades at 26.2 times forward earnings, above its industry average and five-year median. The consensus current-year earnings estimate has slipped 1.4% in four weeks, and Zacks rates the stock a Hold, suggesting limited upside from here.

    This is the main counterweight: even with good news, the stock's high price and slightly falling profit forecasts could cap gains.

Latest
▲2

Martin Marietta's $13.5B Lhoist deal clears path as Q2 hits records

  • Lhoist acquisition clears regulatory hurdle All regulatory approvals are now in for the $13.5 billion Lhoist North America deal, expected to close in Q3 2026. This removes a major uncertainty and should let the company become the top U.S. lime and limestone producer, boosting future earnings and margins.

    This is a new, concrete step that de-risks the largest deal in company history and directly affects MLM's future earnings power.

  • Record Q2 results and raised guidance MLM reported record Q2 revenue of $1.95 billion (up 21%) and adjusted EPS of $5.00, beating estimates. It raised full-year revenue guidance to $7.2–$7.4 billion and reaffirmed EBITDA guidance, showing strong demand for aggregates and lime.

    This is fresh evidence of the company's underlying business strength and supports the bull case for the stock.

  • Premium valuation and lowered earnings estimate Despite the earnings beat, MLM trades at 26.2 times forward earnings, above its industry average and five-year median. The consensus current-year earnings estimate has slipped 1.4% in four weeks, and Zacks rates the stock a Hold, suggesting limited upside from here.

    This is the main counterweight: even with good news, the stock's high price and slightly falling profit forecasts could cap gains.